| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 323 | 389 | 406 | 452 | 398 | 299 | 393 | 376 | 348 | 367 | 463 | 534 | 458 | 465 | 507 | 501 | 375 | 558 | 541 | 538 | 387 | 432 | 439 | 513 | 404 | 451 | 443 | 551 | 372 | 318 |
| Expenses | 265 | 320 | 333 | 374 | 335 | 278 | 328 | 308 | 300 | 302 | 372 | 423 | 361 | 378 | 422 | 441 | 356 | 489 | 466 | 457 | 338 | 377 | 383 | 420 | 349 | 378 | 376 | 429 | 355 | 311 |
| EBITDA | 58 | 70 | 73 | 78 | 63 | 21 | 65 | 68 | 48 | 65 | 91 | 111 | 97 | 87 | 86 | 60 | 19 | 69 | 75 | 81 | 49 | 55 | 56 | 94 | 56 | 73 | 67 | 122 | 17 | 7 |
| Operating Profit % | 18 % | 18 % | 18 % | 17 % | 16 % | 7 % | 16 % | 18 % | 14 % | 18 % | 19 % | 20 % | 21 % | 18 % | 17 % | 12 % | 4 % | 12 % | 14 % | 15 % | 13 % | 12 % | 13 % | 18 % | 14 % | 16 % | 14 % | 22 % | 4 % | 2 % |
| Depreciation | 23 | 24 | 24 | 23 | 20 | 21 | 21 | 21 | 21 | 21 | 22 | 22 | 23 | 24 | 25 | 24 | 27 | 27 | 28 | 27 | 28 | 29 | 29 | 32 | 32 | 32 | 33 | 38 | 39 | 41 |
| Interest | 16 | 16 | 13 | 13 | 12 | 14 | 13 | 14 | 10 | 9 | 8 | 10 | 8 | 8 | 7 | 8 | 11 | 11 | 13 | 13 | 14 | 13 | 14 | 15 | 20 | 19 | 19 | 18 | 17 | 15 |
| Profit Before Tax | 23 | 36 | 42 | 48 | 37 | 10 | 42 | 38 | 23 | 41 | 62 | 81 | 68 | 60 | 62 | 29 | -12 | 33 | 36 | 49 | 10 | 17 | 22 | 47 | 7 | 25 | 24 | 68 | -30 | -47 |
| Tax | 8 | 11 | 13 | 15 | 12 | 3 | 14 | 13 | 8 | 14 | 22 | 30 | 18 | 16 | 16 | 8 | -3 | 8 | 9 | 13 | 3 | 4 | 6 | 13 | 2 | 7 | 7 | 18 | -8 | -12 |
| Net Profit | 16 | 24 | 29 | 33 | 25 | 6 | 28 | 25 | 15 | 27 | 40 | 51 | 51 | 44 | 45 | 21 | -9 | 25 | 26 | 36 | 7 | 13 | 16 | 34 | 5 | 18 | 17 | 50 | -22 | -35 |
| EPS in ₹ | 1.29 | 1.98 | 2.38 | 2.70 | 2.05 | 0.52 | 2.30 | 1.98 | 1.22 | 2.19 | 3.27 | 4.13 | 4.10 | 3.57 | 3.67 | 1.68 | -0.72 | 2.01 | 2.14 | 2.92 | 0.56 | 1.02 | 1.31 | 2.76 | 0.41 | 1.48 | 1.39 | 4.07 | -1.82 | -2.83 |
Hikal
Hikal
221.25
+0.20
(0.09%)
Market Cap
₹2,728.00 Cr
PE Ratio
278.66
Volume
1,05,420.00
Day High - Low
₹223.80 - ₹220.00
52W High-Low
₹464.75 - ₹218.00
Key Fundamentals
Market Cap
2,728.00 Cr
EPS
7.36
PB Ratio
2.36
Book Value
96.86
EBITDA
333.40
Dividend Yield
0.35 %
Industry
Healthcare Sector
Pharmaceuticals ROE Growth %
-
Debt to Equity
0.65
Analyst Rating and Forecast
- By Refinitiv from2 analysts
Actual
Company News
View All News
ICRA Maintains HIKAL's Credit Rating at A- with Stable Outlook Despite Regulatory Challenges2 days ago
ICRA Limited has assigned credit ratings to HIKAL Limited, maintaining the A- rating with stable outlook while citing moderated performance due to USFDA's OAI classification of its Jigani facility and warning letter. The rating factors in deferred pharmaceutical sales from quality checks and customer audits following regulatory action, with the company's ability to recover sales and earnings over H2 FY2026 remaining under monitoring.
Hikal Limited recorded consolidated revenue of Rs. 319 crores for Q2 FY26 with EBITDA of Rs. 8 crores (2.6% margin), impacted by deferred sales worth Rs. 80 crores due to customer risk assessments following FDA warning letter. The pharmaceutical business generated Rs. 190 crores revenue with negative 9.2% EBIT margin, while crop protection segment recorded Rs. 129 crores with negative EBIT, though management expects strong recovery in H2 FY26.
Hikal Limited posted a standalone net loss of Rs 341 million for the quarter ended September 30, 2025, after reversing Rs 807 million in revenue due to incomplete performance obligations. The company faces ongoing challenges from US FDA warning letter impact on pharma sales and pending Supreme Court case regarding environmental compliance with Rs 174.5 million compensation claim.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,810.30 | #1 4,34,351.60 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 76.30 | |
6,490.50 | 1,72,302.40 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 50.50 | |
3,730.40 | 1,26,253.70 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.46 | |
1,525.20 | 1,23,198.70 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.61 | |
1,249.30 | 1,04,268.30 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.75 | |
2,071.40 | 94,612.10 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 63.44 | |
937.25 | 94,309.30 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 41.16 | |
2,249.30 | 92,841.80 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 38.34 | |
1,235.80 | 71,775.50 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 67.24 | |
5,686.50 | 67,990.60 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 53.98 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
4.35 %
Net Income Growth
30.46 %
Cash Flow Change
50.19 %
ROE
22.70 %
ROCE
30.30 %
EBITDA Margin (Avg.)
18.57 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,292 | 1,275 | 1,380 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,386 | 2,487 | 2,529 |
| Fixed Assets | 639 | 623 | 668 | 634 | 713 | 735 | 713 | 880 | 948 | 1,071 | 1,365 |
| Current Assets | 501 | 467 | 577 | 690 | 830 | 775 | 879 | 964 | 939 | 967 | 995 |
| Capital Work in Progress | 62 | 66 | 63 | 118 | 79 | 161 | 254 | 295 | 412 | 414 | 121 |
| Investments | 0 | 0 | 4 | 3 | 1 | 1 | 1 | 11 | 5 | 5 | 10 |
| Other Assets | 591 | 586 | 645 | 788 | 893 | 871 | 946 | 1,028 | 1,020 | 997 | 1,034 |
| Total Liabilities | 1,292 | 1,275 | 1,380 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,386 | 2,487 | 2,529 |
| Current Liabilities | 518 | 374 | 440 | 560 | 603 | 596 | 657 | 769 | 662 | 757 | 790 |
| Non Current Liabilities | 242 | 337 | 334 | 312 | 327 | 355 | 323 | 376 | 591 | 543 | 477 |
| Total Equity | 533 | 564 | 605 | 669 | 756 | 817 | 933 | 1,068 | 1,134 | 1,188 | 1,262 |
| Reserve & Surplus | 516 | 547 | 589 | 653 | 732 | 792 | 909 | 1,043 | 1,109 | 1,163 | 1,238 |
| Share Capital | 16 | 16 | 16 | 16 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -10 | -2 | -2 | 4 | 6 | 20 | -24 | 4 | 15 | -14 | 0 |
| Investing Activities | -43 | -64 | -102 | -110 | -125 | -164 | -156 | -284 | -292 | -174 | -137 |
| Operating Activities | 102 | 186 | 164 | 139 | 186 | 285 | 229 | 294 | 315 | 187 | 280 |
| Financing Activities | -69 | -124 | -63 | -25 | -55 | -101 | -97 | -6 | -8 | -27 | -144 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.83 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 4.81 % | 6.13 % | 6.55 % | 6.67 % | 6.78 % | 6.06 % | 5.69 % | 5.36 % | 4.23 % |
| DIIs | 0.57 % | 0.62 % | 0.50 % | 0.35 % | 0.88 % | 0.89 % | 1.22 % | 1.57 % | 2.19 % | 2.78 % | 3.12 % | 3.15 % | 3.53 % | 3.17 % | 3.58 % | 3.48 % | 3.80 % | 4.02 % | 5.16 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 20.01 % | 19.69 % | 18.74 % | 18.50 % | 18.06 % | 18.53 % | 19.21 % | 18.78 % | 18.72 % | 18.57 % | 18.19 % | 17.02 % | 16.45 % | 16.31 % | 15.81 % | 16.64 % | 16.57 % | 16.75 % | 16.66 % |
| Others | 10.65 % | 10.93 % | 11.99 % | 12.38 % | 12.29 % | 11.81 % | 10.80 % | 10.83 % | 10.25 % | 9.80 % | 5.03 % | 4.85 % | 4.62 % | 5.01 % | 4.99 % | 4.97 % | 5.08 % | 5.02 % | 5.10 % |
| No of Share Holders | 53,021 | 61,870 | 68,233 | 72,450 | 75,341 | 79,105 | 78,500 | 75,780 | 75,167 | 75,110 | 76,126 | 74,657 | 71,840 | 70,978 | 71,912 | 71,801 | 68,907 | 71,391 | 73,404 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1.2 | 1.2 | 1.2 | 1.2 | 2 | 1.6 | 1.2 | 1.2 | 0.8 |
| Dividend Yield (%) | 0.00 | 0.87 | 0.69 | 1.72 | 0.84 | 0.5 | 0.57 | 0.45 | 0.3 | 0.36 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Jun 2018 |  Bonus | 1:2 | 22 Jun 2018 | 156.67 | 157.05 |
| 16 Feb 2021 |  Dividend | ₹ 1.00 /share | 15 Feb 2021 | 178.70 | 167.05 |
| 26 Aug 2021 | Dividend | ₹ 1.00 /share | 25 Aug 2021 | 313.95 | 626.35 |
| 24 Feb 2022 | Dividend | ₹ 1.20 /share | 23 Feb 2022 | 425.10 | 375.95 |
| 15 Sept 2022 | Dividend | ₹ 0.40 /share | 14 Sept 2022 | 381.40 | 371.95 |
| 14 Feb 2023 | Dividend | ₹ 0.60 /share | 14 Feb 2023 | 350.60 | 329.40 |
| 19 Sept 2023 | Dividend | ₹ 0.60 /share | 18 Sept 2023 | 284.00 | 309.55 |
| 20 Feb 2024 | Dividend | ₹ 0.60 /share | 20 Feb 2024 | 297.65 | 289.80 |
| 04 Sept 2024 | Dividend | ₹ 0.60 /share | 04 Sept 2024 | 293.05 | 329.15 |
| 17 Sept 2024 |  Annual General Meeting | NA | 17 Sept 2024 | 327.20 | 384.00 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 370.10 | 376.55 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 338.10 | 358.80 |
| 08 Feb 2025 | Dividend | ₹ 0.60 /share | 07 Feb 2025 | 358.80 | 376.90 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 397.75 | 407.60 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 329.80 | 307.35 |
| 02 Sept 2025 | Dividend | ₹ 0.80 /share | 02 Sept 2025 | 407.60 | 256.30 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 307.35 | 262.90 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 240.20 | 238.38 |
Announcements
Announcement under Regulation 30 (LODR)-Credit Rating
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Nov 13, 2025Submission Of Unaudited Standalone And Consolidated Financial Results For The Quarter And The Half Year Ended September 30 2025Nov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Nov 13, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Intimation Of Cancellation Of Earnings Group Conference CallNov 06, 2025
Nov 06, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Oct 31, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025Oct 31, 2025
Oct 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsOct 07, 2025
Oct 07, 2025Newspaper Advertisement Regarding Saksham Niveshak For Updating KYC And Re-Lodgment Of Transfer Requests Of Physical SharesOct 07, 2025
Oct 07, 2025Change Of Email Address Of The Registrar And Share Transfer Agent (RTA) Of The CompanyOct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorOct 01, 2025
Oct 01, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationSep 26, 2025
Sep 26, 2025Voting Results Under Regulation 44 Of The SEBI Listing RegulationsSep 23, 2025
Sep 23, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Sep 23, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationSep 23, 2025
Sep 23, 2025Submission Of Copy Of The Letter Sent To Shareholders To Access The Integrated Annual Report 2024-25Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2025
Aug 27, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 26, 2025
Aug 26, 2025Notice Of 37Th Annual General Meeting Of The CompanyAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 21, 2025
Aug 21, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 07, 2025
Aug 07, 2025Intimation Of 37Th Annual General Meeting Book Closure And Record DateAug 07, 2025
Aug 07, 2025Intimation Of 37Th Annual General Meeting Book Closure And Record DateAug 07, 2025
Aug 07, 2025Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Jul 31, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 23, 2025
Jul 23, 2025Disclosure under Regulation 30A of LODRJul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Disclosure Under Regulation 30 SEBI Listing RegulationJun 16, 2025
Jun 16, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth | 0.84% | 1177975 | 0.40% | 0.55% | |
 Kotak Healthcare Fund Direct - Growth | 0.00% | -130000 | -0.70% | -1.04% | |
 Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 0.11% | 1402 | -0.01% | -0.02% | |
 Groww Nifty Total Market Index Fund Direct - Growth | 0.00% | 5 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.07% | 3 | 0.00% | 0.00% | |
 Angel One Nifty Total Market Index Fund Direct - Growth | 0.00% | 2 | 0.00% | 0.00% | |
| Bandhan Nifty Total Market Index Fund Direct-Growth | 0.00% | -2 | 0.00% | 0.00% | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 0.00% | 2 | 0.00% | 0.00% | |
 Samco Multi Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.10% | |
 Tata India Pharma & Healthcare Fund Direct-Growth | 0.71% | 0 | -0.05% | -0.06% | |
| Tata Small Cap Fund Direct - Growth | 0.67% | 0 | -0.04% | -0.07% |
Technical Indicators
RSI(14)
Neutral 35.02
ATR(14)
Less Volatile 6.59
STOCH(9,6)
Oversold 17.11
STOCH RSI(14)
Neutral 37.43
MACD(12,26)
Bearish -0.60
ADX(14)
Weak Trend 24.95
UO(9)
Bearish 46.53
ROC(12)
Downtrend But Slowing Down -4.65
WillR(14)
Oversold -87.05
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
